Galectin Therapeutics Inc (GALT): R&D Expense
$14.29M
Year ended 2025-12-31
$8.91M
Trailing 12 months to 2026-06-30
-23.4%
3-year compound annual growth
-4.5%
5-year compound annual growth
+0.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $14.29M | -60.9% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $36.57M | +13.8% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $32.13M | +1.2% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $31.74M | +33.2% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $23.82M | +32.5% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $17.98M | +140.7% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $7.47M | +15.4% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $6.47M | -44.8% | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | $11.72M | -23.5% | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | $15.32M | +16.9% | 2018-03-29, From 2016-01-01 |
| 2015-12-31 | $13.11M | +55.7% | 2017-03-28, From 2015-01-01 |
| 2014-12-31 | $8.43M | +48.1% | 2016-03-15, From 2014-01-01 |
| 2013-12-31 | $5.69M | +25.6% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $4.53M | +27.4% | 2015-03-18, From 2012-01-01 |
| 2011-12-31 | $3.55M | +233.2% | 2013-03-29, From 2011-01-01 |
| 2010-12-31 | $1.07M | n/a | 2012-03-30, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Galectin Therapeutics Inc (GALT) | 2025-12-31 | $14.29M | -60.9% |
| Propanc Biopharma, Inc. (PPCB) | 2025-06-30 | $223.7K | -9.8% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $11.80M | -12.4% |
| Genelux Corp (GNLX) | 2025-12-31 | $19.85M | +4.5% |
| Evofem Biosciences, Inc. (EVFM) | 2024-12-31 | $1.84M | -37.2% |
| Quoin Pharmaceuticals Ltd. (QNRX) | 2025-12-31 | $9.80M | +172.1% |
| Nexentis Technologies Inc. (NXTS) | 2025-12-31 | $179.0K | -51.5% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $10.75M | -16.6% |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $4.87M | +63.6% |
Compare GALT, PPCB, MRKR, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗